{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:35:06Z","timestamp":1791930906867,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan","award":["JP20K16957"],"award-info":[{"award-number":["JP20K16957"]}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"crossref","award":["202310009"],"award-info":[{"award-number":["202310009"]}],"id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10620-025-09276-5","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T12:57:22Z","timestamp":1754139442000},"page":"4140-4151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Berberine Prevents NSAID-Induced Small Intestinal Injury by Protecting Intestinal Barrier and Inhibiting Inflammasome-Associated Activation"],"prefix":"10.1007","volume":"70","author":[{"given":"Mikako","family":"Ishiguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4601-6644","authenticated-orcid":false,"given":"Masahiro","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyunki","family":"Toyosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"9276_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-019-01657-8","volume":"55","author":"T Watanabe","year":"2020","unstructured":"Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. J Gastroenterol 2020;55:481\u2013495.","journal-title":"J Gastroenterol"},{"key":"9276_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","volume":"359","author":"JQ Huang","year":"2002","unstructured":"Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14\u201322.","journal-title":"Lancet"},{"key":"9276_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","volume":"128","author":"L Maiden","year":"2005","unstructured":"Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005;128:1172\u20131178.","journal-title":"Gastroenterology"},{"key":"9276_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000190403","volume":"78","author":"S Sugimori","year":"2008","unstructured":"Sugimori S, Watanabe T, Tabuchi M et al. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 2008;78:208\u2013213.","journal-title":"Digestion"},{"key":"9276_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.gie.2008.06.007","volume":"69","author":"A Fukumoto","year":"2009","unstructured":"Fukumoto A, Tanaka S, Shishido T, Takemura Y, Oka S, Chayama K. Comparison of detectability of small-bowel lesions between capsule endoscopy and double-balloon endoscopy for patients with suspected small-bowel disease. Gastrointest Endosc 2009;69:857\u2013865.","journal-title":"Gastrointest Endosc"},{"key":"9276_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jgh.13424","volume":"32","author":"Y Kono","year":"2017","unstructured":"Kono Y, Kawano S, Takaki A et al. Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs. J Gastroenterol Hepatol 2017;32:136\u2013145.","journal-title":"J Gastroenterol Hepatol"},{"key":"9276_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1542-3565(04)00603-2","volume":"3","author":"DY Graham","year":"2005","unstructured":"Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55\u201359.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9276_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","volume":"102","author":"A Lanas","year":"2007","unstructured":"Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007;102:507\u2013515.","journal-title":"Am J Gastroenterol"},{"key":"9276_CR9","first-page":"728","volume":"104","author":"FL Lanza","year":"2009","unstructured":"Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728\u2013738.","journal-title":"Am J Gastroenterol"},{"key":"9276_CR10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","volume":"141","author":"JL Wallace","year":"2011","unstructured":"Wallace JL, Syer S, Denou E et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 2011;141:1314-1322.e1-5.","journal-title":"Gastroenterology"},{"key":"9276_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cgh.2015.10.022","volume":"14","author":"E Washio","year":"2016","unstructured":"Washio E, Esaki M, Maehata Y et al. Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: a randomized, placebo-controlled trial. Clin Gastroenterol Hepatol 2016;14:809-815.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9276_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000374106","volume":"91","author":"K Takeuchi","year":"2015","unstructured":"Takeuchi K, Satoh H. NSAID-induced small intestinal damage\u2013roles of various pathogenic factors. Digestion 2015;91:218\u2013232.","journal-title":"Digestion"},{"key":"9276_CR13","doi-asserted-by":"publisher","first-page":"32587","DOI":"10.1038\/srep32587","volume":"6","author":"K Otani","year":"2016","unstructured":"Otani K, Watanabe T, Shimada S et al. Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome. Sci Rep 2016;6:32587.","journal-title":"Sci Rep"},{"key":"9276_CR14","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s12325-020-01338-6","volume":"37","author":"M Rekatsina","year":"2020","unstructured":"Rekatsina M, Paladini A, Cifone MG, Lombardi F, Pergolizzi JV, Varrassi G. Influence of microbiota on NSAID enteropathy: A systematic review of current knowledge and the role of probiotics. Adv Ther 2020;37:1933\u20131945.","journal-title":"Adv Ther"},{"key":"9276_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.metabol.2008.08.013","volume":"58","author":"WJ Kong","year":"2009","unstructured":"Kong WJ, Zhang H, Song DQ et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 2009;58:109\u2013119.","journal-title":"Metabolism"},{"key":"9276_CR16","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/s41598-019-48331-w","volume":"9","author":"M Takahara","year":"2019","unstructured":"Takahara M, Takaki A, Hiraoka S et al. Berberine improved experimental chronic colitis by regulating interferon-\u03b3- and IL-17A-producing lamina propria CD4(+) T cells through AMPK activation. Sci Rep 2019;9:11934.","journal-title":"Sci Rep"},{"key":"9276_CR17","doi-asserted-by":"publisher","first-page":"1083788","DOI":"10.3389\/fimmu.2022.1083788","volume":"13","author":"C Zhu","year":"2022","unstructured":"Zhu C, Li K, Peng XX et al. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy. Front Immunol 2022;13:1083788.","journal-title":"Front Immunol"},{"key":"9276_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00535-009-0005-2","volume":"44","author":"Y Watanabe-Fukuda","year":"2009","unstructured":"Watanabe-Fukuda Y, Yamamoto M, Miura N et al. Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine. J Gastroenterol 2009;44:380\u2013389.","journal-title":"J Gastroenterol"},{"key":"9276_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/fcp.12509","volume":"34","author":"G Chao","year":"2020","unstructured":"Chao G, Ye F, Yuan Y, Zhang S. Berberine ameliorates non-steroidal anti-inflammatory drugs-induced intestinal injury by the repair of enteric nervous system. Fundam Clin Pharmacol 2020;34:238\u2013248.","journal-title":"Fundam Clin Pharmacol"},{"key":"9276_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41021-021-00205-2","volume":"43","author":"G Chao","year":"2021","unstructured":"Chao G, Wang Q, Ye F, Zhang S. Gene expression analysis in NSAID-induced rat small intestinal disease model with the intervention of berberine by the liquid chip technology. Genes Environ 2021;43:32.","journal-title":"Genes Environ"},{"key":"9276_CR21","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"9276_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.fitote.2009.02.005","volume":"80","author":"L Gu","year":"2009","unstructured":"Gu L, Li N, Li Q et al. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells. Fitoterapia 2009;80:241\u2013248.","journal-title":"Fitoterapia"},{"key":"9276_CR23","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/infdis\/jir147","volume":"203","author":"L Gu","year":"2011","unstructured":"Gu L, Li N, Gong J, Li Q, Zhu W, Li J. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis 2011;203:1602\u20131612.","journal-title":"J Infect Dis"},{"key":"9276_CR24","doi-asserted-by":"publisher","first-page":"e61944","DOI":"10.1371\/journal.pone.0061944","volume":"8","author":"M Cao","year":"2013","unstructured":"Cao M, Wang P, Sun C, He W, Wang F. Amelioration of IFN-\u03b3 and TNF-\u03b1-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS One 2013;8:e61944.","journal-title":"PLoS One"},{"key":"9276_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med 2018;50:1\u20139.","journal-title":"Exp Mol Med"},{"key":"9276_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/mi.2016.55","volume":"10","author":"SS Seregin","year":"2017","unstructured":"Seregin SS, Golovchenko N, Schaf B, Chen J, Eaton KA, Chen GY. NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury. Mucosal Immunol 2017;10:434\u2013445.","journal-title":"Mucosal Immunol"},{"key":"9276_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00018-024-05124-3","volume":"81","author":"G Fr\u00fchbeck","year":"2024","unstructured":"Fr\u00fchbeck G, G\u00f3mez-Ambrosi J, Ram\u00edrez B et al. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes. Cell Mol Life Sci 2024;81:77.","journal-title":"Cell Mol Life Sci"},{"key":"9276_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/mi.2017.19","volume":"10","author":"N Zmora","year":"2017","unstructured":"Zmora N, Levy M, Pevsner-Fishcer M, Elinav E. Inflammasomes and intestinal inflammation. Mucosal Immunol 2017;10:865\u2013883.","journal-title":"Mucosal Immunol"},{"key":"9276_CR29","doi-asserted-by":"publisher","first-page":"107496","DOI":"10.1016\/j.pharmthera.2020.107496","volume":"209","author":"WJ Kong","year":"2020","unstructured":"Kong WJ, Vernieri C, Foiani M, Jiang JD. Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders. Pharmacol Ther 2020;209:107496.","journal-title":"Pharmacol Ther"},{"key":"9276_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41575-023-00766-3","volume":"20","author":"A Horowitz","year":"2023","unstructured":"Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol 2023;20:417\u2013432.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9276_CR31","doi-asserted-by":"publisher","first-page":"109206","DOI":"10.1016\/j.biopha.2019.109206","volume":"118","author":"Q Hou","year":"2019","unstructured":"Hou Q, Zhu S, Zhang C et al. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice. Biomed Pharmacother 2019;118:109206.","journal-title":"Biomed Pharmacother"},{"key":"9276_CR32","doi-asserted-by":"publisher","first-page":"1517121","DOI":"10.3389\/fcell.2025.1517121","volume":"13","author":"J Ren","year":"2025","unstructured":"Ren J, Huang S. Intestinal organoids in inflammatory bowel disease: advances, applications, and future directions. Front Cell Dev Biol 2025;13:1517121.","journal-title":"Front Cell Dev Biol"},{"key":"9276_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/mi.2015.89","volume":"9","author":"A Higashimori","year":"2016","unstructured":"Higashimori A, Watanabe T, Nadatani Y et al. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. Mucosal Immunol 2016;9:659\u2013668.","journal-title":"Mucosal Immunol"},{"key":"9276_CR34","doi-asserted-by":"publisher","first-page":"13058","DOI":"10.3390\/ijms252313058","volume":"25","author":"V Scalavino","year":"2024","unstructured":"Scalavino V, Piccinno E, Giannelli G, Serino G. Inflammasomes in intestinal disease: mechanisms of activation and therapeutic strategies. Int J Mol Sci 2024;25:13058.","journal-title":"Int J Mol Sci"},{"key":"9276_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2013-304713","volume":"63","author":"T Watanabe","year":"2014","unstructured":"Watanabe T, Tanigawa T, Shiba M et al. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients. Gut 2014;63:409\u2013414.","journal-title":"Gut"},{"key":"9276_CR36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009;9:799\u2013809.","journal-title":"Nat Rev Immunol"},{"key":"9276_CR37","doi-asserted-by":"publisher","first-page":"767456","DOI":"10.3389\/fimmu.2021.767456","volume":"12","author":"LW Kaminsky","year":"2021","unstructured":"Kaminsky LW, Al-Sadi R, Ma TY. IL-1\u03b2 and the intestinal epithelial tight junction barrier. Front Immunol 2021;12:767456.","journal-title":"Front Immunol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09276-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:03:24Z","timestamp":1765299804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09276-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9276"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09276-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests, as defined by\n                      Nature Research\n                      or any other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}